Home › BIOMET MICROFIXATION, INC › 1.5 LACTOSORB SYSTEM
1.5 LACTOSORB SYSTEM
BIOMET MICROFIXATION, INC · Model 915-2217 · UDI-DI 00841036054885
NHB
Prescription
1
510(k) clearances
178
Adverse events
15
Recalls
35
Facilities
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
| 2025-02-25 | Stryker Corporation | There is a potential for blister seals on the product to present a bubble on the seal area of the packaging. This seal acts as a sterile barrier and, in this event, indicates that |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.